Earnings ·
Pediatrix Medical Group reported second quarter 2026 results with net revenue of $488 million, up 4.0% year-over-year…
MDPediatrix Medical Group, Inc.
Pediatrix Medical Group reported second quarter 2026 results with net revenue of $488 million, up 4.0% year-over-year, driven by acquisition growth and improved reimbursement metrics despite a 2.1% decline in same-unit patient volume. The company generated net income of $40 million, or $0.49 per diluted share, compared to $39 million ($0.46) in the prior year period. Adjusted EBITDA reached $76 million, up from $73 million, while adjusted EPS was $0.63 versus $0.53 previously. For the six-month period, net income totaled $69 million ($0.85 per share) on revenue of $964 million. Management reaffirmed its full-year 2026 Adjusted EBITDA guidance of $280 million to $300 million and utilized $42.7 million for share repurchases during the quarter. Pediatrix Medical Group operates in the healthcare industry, providing physician services including neonatology, obstetrics, and pediatric subspecialties.